• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

膀胱镜检查对血尿成年患者膀胱癌的诊断准确性:来自欧洲泌尿外科学会指南办公室的系统评价

The Diagnostic Accuracy of Cystoscopy for Detecting Bladder Cancer in Adults Presenting with Haematuria: A Systematic Review from the European Association of Urology Guidelines Office.

作者信息

Devlies Wout, de Jong Joep J, Hofmann Fabian, Bruins Harman Max, Zuiverloon Tahlita C M, Smith Emma Jane, Yuan Yuhong, van Rhijn Bas W G, Mostafid Hugh, Santesso Nancy, Violette Phil, Omar Muhammad Imran

机构信息

Department of Urology, UZ Leuven, Leuven, Belgium.

Department of Urology, Erasmus University Medical Center, Rotterdam, The Netherlands.

出版信息

Eur Urol Focus. 2024 Jan;10(1):115-122. doi: 10.1016/j.euf.2023.08.002. Epub 2023 Aug 24.

DOI:10.1016/j.euf.2023.08.002
PMID:37633791
Abstract

CONTEXT

Haematuria can be macroscopic (visible haematuria [VH]) or microscopic (nonvisible haematuria [NVH]), and may be caused by a number of underlying aetiologies. Currently, in case of haematuria, cystoscopy is the standard diagnostic tool to screen the entire bladder for malignancy.

OBJECTIVE

The objective of this systematic review is to determine the diagnostic test accuracy of cystoscopy (compared with other tests, eg, computed tomography, urine biomarkers, and urine cytology) for detecting bladder cancer in adults.

EVIDENCE ACQUISITION

A systematic review of the literature was performed according to the Cochrane Handbook for Systematic Reviews of Diagnostic Test Accuracy and Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) extension for diagnostic test accuracy studies' checklist. The MEDLINE, Embase, Cochrane CENTRAL, and Cochrane CDSR databases (via Ovid) were searched up to July 13, 2022. The population comprises patients presenting with either VH or NVH, without previous urological cancers. Two reviewers independently screened all articles, searched reference lists of retrieved articles, and performed data extraction. The risk of bias was assessed using Quality Assessment of Diagnostic Accuracy Studies (QUADAS-2).

EVIDENCE SYNTHESIS

Overall, nine studies were included in the qualitative analysis. Seven out of nine included trials covered the use of cystoscopy in comparison with radiological imaging. Overall, sensitivity of cystoscopy ranged from 87% to 100%, specificity from 64% to 100%, positive predictive value from 79% to 98%, and negative predictive values between 98% and 100%. Two trials compared enhanced or air cystoscopy versus conventional cystoscopy. Overall sensitivity of conventional white light cystoscopy ranged from 47% to 100% and specificity from 93.4% to 100%.

CONCLUSIONS

The true accuracy of cystoscopy for the detection of bladder cancer within the context of haematuria has not been studied extensively, resulting in inconsistent data regarding its performance for patients with haematuria. In comparison with imaging modalities, a few trials have prospectively assessed the diagnostic performance of cystoscopy, confirming very high accuracy for cystoscopy, exceeding the diagnostic value of any other imaging test.

PATIENT SUMMARY

Evidence of tests for detecting bladder cancer in adults presenting with haematuria (blood in urine) was reviewed. The most common test used was cystoscopy, which remains the current standard for diagnosing bladder cancer.

摘要

背景

血尿可分为肉眼血尿(可见血尿[VH])或镜下血尿(不可见血尿[NVH]),可能由多种潜在病因引起。目前,对于血尿患者,膀胱镜检查是筛查整个膀胱是否存在恶性肿瘤的标准诊断工具。

目的

本系统评价的目的是确定膀胱镜检查(与其他检查,如计算机断层扫描、尿液生物标志物和尿液细胞学检查相比)在检测成人膀胱癌方面的诊断试验准确性。

证据获取

根据《Cochrane系统评价诊断试验准确性手册》以及《系统评价与Meta分析优先报告条目》(PRISMA)中关于诊断试验准确性研究的扩展清单,对文献进行系统评价。检索MEDLINE、Embase、Cochrane CENTRAL和Cochrane CDSR数据库(通过Ovid),检索截至2022年7月13日的文献。研究对象包括出现VH或NVH且既往无泌尿系统癌症的患者。两名研究者独立筛选所有文章,检索所获文章的参考文献列表,并进行数据提取。使用诊断准确性研究质量评估(QUADAS - 2)评估偏倚风险。

证据综合

总体而言,9项研究纳入了定性分析。9项纳入试验中的7项涉及膀胱镜检查与放射影像学检查的比较。总体而言,膀胱镜检查的敏感性范围为87%至100%,特异性为64%至100%,阳性预测值为79%至98%,阴性预测值在98%至100%之间。两项试验比较了增强或空气膀胱镜检查与传统膀胱镜检查。传统白光膀胱镜检查的总体敏感性范围为47%至100%,特异性为93.4%至100%。

结论

在血尿背景下,膀胱镜检查检测膀胱癌的真正准确性尚未得到广泛研究,导致关于其在血尿患者中的表现的数据不一致。与影像学检查相比,少数试验前瞻性评估了膀胱镜检查的诊断性能,证实膀胱镜检查具有非常高的准确性,超过任何其他影像学检查的诊断价值。

患者总结

对出现血尿(尿液中带血)的成人检测膀胱癌的检查证据进行了综述。最常用的检查是膀胱镜检查,它仍然是目前诊断膀胱癌的标准。

相似文献

1
The Diagnostic Accuracy of Cystoscopy for Detecting Bladder Cancer in Adults Presenting with Haematuria: A Systematic Review from the European Association of Urology Guidelines Office.膀胱镜检查对血尿成年患者膀胱癌的诊断准确性:来自欧洲泌尿外科学会指南办公室的系统评价
Eur Urol Focus. 2024 Jan;10(1):115-122. doi: 10.1016/j.euf.2023.08.002. Epub 2023 Aug 24.
2
Evaluation of diagnostic strategies for bladder cancer using computed tomography (CT) urography, flexible cystoscopy and voided urine cytology: results for 778 patients from a hospital haematuria clinic.使用计算机断层扫描(CT)尿路造影、软性膀胱镜检查和尿液细胞学检查评估膀胱癌的诊断策略:来自医院血尿诊所的 778 例患者的结果。
BJU Int. 2012 Jul;110(1):84-94. doi: 10.1111/j.1464-410X.2011.10664.x. Epub 2011 Nov 28.
3
Diagnostic tests and algorithms used in the investigation of haematuria: systematic reviews and economic evaluation.用于血尿调查的诊断测试和算法:系统评价与经济评估
Health Technol Assess. 2006 Jun;10(18):iii-iv, xi-259. doi: 10.3310/hta10180.
4
Systematic Review of the Incidence of and Risk Factors for Urothelial Cancers and Renal Cell Carcinoma Among Patients with Haematuria.血尿患者尿路上皮癌和肾细胞癌的发病率及危险因素的系统评价。
Eur Urol. 2022 Aug;82(2):182-192. doi: 10.1016/j.eururo.2022.03.027. Epub 2022 Apr 5.
5
Diagnostic Tests for Female Bladder Outlet Obstruction: A Systematic Review from the European Association of Urology Non-neurogenic Female LUTS Guidelines Panel.女性膀胱出口梗阻的诊断测试:来自欧洲泌尿外科学会非神经源性女性下尿路症状指南小组的系统评价
Eur Urol Focus. 2022 Jul;8(4):1015-1030. doi: 10.1016/j.euf.2021.09.003. Epub 2021 Sep 17.
6
Non-visible haematuria for the Detection of Bladder, Upper Tract, and Kidney Cancer: An Updated Systematic Review and Meta-analysis.非可见性血尿检测膀胱癌、上尿路和肾癌:一项更新的系统评价和荟萃分析。
Eur Urol. 2020 May;77(5):583-598. doi: 10.1016/j.eururo.2019.10.010. Epub 2019 Nov 30.
7
Does urinary cytology have a role in haematuria investigations?尿细胞学检查在血尿检查中有作用吗?
BJU Int. 2019 Jan;123(1):74-81. doi: 10.1111/bju.14459. Epub 2018 Aug 29.
8
Factors affecting the timeliness and adequacy of haematuria assessment in bladder cancer: a systematic review.影响膀胱癌血尿评估及时性和充分性的因素:一项系统评价
BJU Int. 2017 May;119 Suppl 5:10-18. doi: 10.1111/bju.13821.
9
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
10
Outcomes of haematuria referrals: two-year data from a single large university hospital in Denmark.血尿转诊的结果:来自丹麦一家大型大学医院的两年数据。
Scand J Urol. 2017 Aug;51(4):282-289. doi: 10.1080/21681805.2017.1310759. Epub 2017 Apr 13.

引用本文的文献

1
TRP channels and cancer modulation: a voyage beyond metabolic reprogramming, oxidative stress and the advent of nanotechnologies in targeted therapy.瞬时受体电位通道与癌症调控:超越代谢重编程、氧化应激以及靶向治疗中纳米技术出现的探索之旅。
J Exp Clin Cancer Res. 2025 Aug 14;44(1):240. doi: 10.1186/s13046-025-03495-4.
2
Detection of genome-wide methylation changes in bladder cancer by long-read sequencing of urinary DNA.通过尿液DNA长读测序检测膀胱癌全基因组甲基化变化
Clin Epigenetics. 2025 Aug 11;17(1):141. doi: 10.1186/s13148-025-01946-5.
3
Evaluating Cost-Effective Strategies for Asymptomatic Microhematuria Diagnosis: A Risk-Based Alternative to the American Urological Association Guidelines.
评估无症状性镜下血尿诊断的成本效益策略:一种基于风险的替代美国泌尿外科学会指南的方法。
J Surg Oncol. 2025 Jun;131(8):1661-1669. doi: 10.1002/jso.28148. Epub 2025 May 13.
4
Novel Urinary Biomarkers for the Detection of Bladder Cancer.用于检测膀胱癌的新型尿液生物标志物。
Cancers (Basel). 2025 Apr 10;17(8):1283. doi: 10.3390/cancers17081283.
5
Validation of Cxbladder Triage and Monitor as an Adjunct to Urothelial Carcinoma Diagnosis and Surveillance in a Single Centre.在单一中心验证Cxbladder分诊与监测作为尿路上皮癌诊断和监测辅助手段的效果
Res Rep Urol. 2025 Mar 18;17:87-94. doi: 10.2147/RRU.S516994. eCollection 2025.
6
Unleashing the power of urine‑based biomarkers in diagnosis, prognosis and monitoring of bladder cancer (Review).释放基于尿液的生物标志物在膀胱癌诊断、预后和监测中的力量(综述)。
Int J Oncol. 2025 Mar;66(3). doi: 10.3892/ijo.2025.5724. Epub 2025 Feb 7.
7
Xpert Bladder Cancer Detection in Emergency Setting Assessment (XESA Project): A Prospective, Single-centre Trial.急诊环境下Xpert膀胱癌检测评估(XESA项目):一项前瞻性单中心试验。
Eur Urol Open Sci. 2024 Dec 31;71:172-179. doi: 10.1016/j.euros.2024.09.001. eCollection 2025 Jan.
8
Diagnostic Performance of GeneXpert BC as a Triage Test for Patients Presenting with Macroscopic Hematuria Suspicious for Urinary Bladder Cancer: A Multicenter Prospective Case-Control Study.GeneXpert BC作为对疑似膀胱癌的肉眼血尿患者进行分流检测的诊断性能:一项多中心前瞻性病例对照研究
Eur Urol Open Sci. 2024 Nov 2;70:158-166. doi: 10.1016/j.euros.2024.10.016. eCollection 2024 Dec.
9
Urine-based SERS and multivariate statistical analysis for identification of non-muscle-invasive bladder cancer and muscle-invasive bladder cancer.基于尿液的 SERS 和多元统计分析用于鉴别非肌肉浸润性膀胱癌和肌肉浸润性膀胱癌。
Anal Bioanal Chem. 2024 Dec;416(29):6973-6984. doi: 10.1007/s00216-024-05595-0. Epub 2024 Oct 17.
10
The Simultaneous Use of Bladder Epicheck and Urinary Cytology Can Improve the Sensitivity and Specificity of Diagnostic Follow-Up of Urothelial Lesions: Up-to-Date Data from a Multi-Institutional Cohort.膀胱上皮检查与尿细胞学联合应用可提高尿路上皮病变诊断随访的敏感性和特异性:来自多机构队列的最新数据
Diseases. 2024 Sep 18;12(9):219. doi: 10.3390/diseases12090219.